Augmented reality technology for surgeons was presented at the Bioprom Forum
Russian scientists have presented new developments that are ready to be put into practice. They were first demonstrated at the international Bioprom Forum in Gelendzhik. Among the innovations is an augmented reality system for surgeons, as well as unique drugs for the treatment of oncological diseases. Yaroslav Bogat, a correspondent of Izvestia, spoke about technologies that will change modern medicine on October 6.
The new technology allows you to use augmented reality right during the operation: one swipe and all the patient data is in front of the surgeon's eyes. The surgeon's accuracy becomes higher, the risk is lower, and the patient can literally be seen through.
The development of the Russian University of Medicine could be called a cheat sheet for surgeons, because even before the first incision with a scalpel, CT or MRI results can be applied directly to the desired area.
"The time spent on the active phase of the operation is reduced by half," said Leonid Prokhorenko, a researcher at the Laboratory of Medical and Robotic Digital Technologies at the Russian University of Medicine.
110 companies, as well as leading universities, scientific institutes, state corporations and start-ups, present their developments in the field of biotechnology. Every high—tech novelty is a market demand that needs domestic innovations.
"The problem with the matrices that are currently on the market is their rigidity, which harms brain tissues," explained Arina Gaisina, PR specialist at the LIFT Scientific Center.
But the first Russian matrix for monitoring activity during open—brain surgery is flexible - it should simplify the work of neurosurgeons. The pharmaceutical industry is not standing still: next year, a drug for the treatment of breast cancer will be available to patients.
"It does not have hematological toxicity like our competitors, it can be used in a later line, that is, it is more effective," said Dmitry Shkil, Director of Drug development at the HimRar Group of companies.
There are also successes in the prevention of infectious diseases. Russian specialists have presented a vaccine for revaccination against whooping cough, diphtheria and tetanus.
"The vaccine has shown very good results in clinical trials. A very stable immune response against these infections has been obtained and formed. This vaccine will be produced in Perm on Microgen's premises in up to five million doses annually. This covers all the needs of the Russian Federation as a whole," said Sergey Tsyb, State Secretary of Rostec State Corporation.
A robotic complex for 3D printing was also presented here. It can repair skin and soft tissues, and the robot adjusts itself to the specific damage. And Sechenov University has created the first domestic hemodialysis machine.
"The device received a registration certificate in May of this year. Up to 60,000 people in Russia need hemodialysis every year," said Yana Svetocheva, manager of the Advanced Engineering School at Sechenov University.
The forum also talks about how to transfer them from laboratories to production faster. And it's not just about medicine: food security also depends on biotechnologies today.
"You buy dairy products — they are all made by live milk bacteria <...>. That is, all the products that we buy in stores today are bioeconomy products. And from here it should be understood that in addition to the fact that we already live in a bioeconomical environment, biosafety issues are coming to the first level," said Mikhail Kovalchuk, President of the Kurchatov Institute Research Center.
The Bioprom International Forum is a kind of benchmark for the entire industry. Based on projects, figures, and solutions, it is clear what is already working, what is stalling, and where the next breakthrough in biotechnology will go.
"The introduction of innovative technologies in medicine and the pharmaceutical industry, agriculture and housing and communal services largely determines the quality of people's lives, their health and environmental well-being," said Denis Manturov, First Deputy Prime Minister.
The strategy for the development of bioeconomics in Russia has been approved until 2036.
On October 5, the Russian government approved the bioeconomy development strategy on behalf of Russian President Vladimir Putin. According to Prime Minister Mikhail Mishustin, the document will determine the priority areas of application of biotechnologies for the next 10 years and a longer-term perspective. They will cover the agro-industrial complex, medicine, veterinary medicine, energy, housing and communal services and ecology.
The strategy provides for the creation of conditions for enterprises that produce products based on biological resources and living microorganisms. Among the promising areas, the prime minister named new materials, fuels, fertilizers, feed additives, medicines and medical products.
Переведено сервисом «Яндекс Переводчик»